Skip to main content

Table 9 Descriptive analysis of the studied cases according to DLP and effective dose reduction in each age group

From: Diagnostic performance of 320 cardiac MDCT angiography in assessment of PDA either isolated or associated with duct dependent congenital heart disease

Age (months)

No

DLP

Effective dose reduction

Mean ± SD

Mean ± SD

< 4 months

18

77.83 ± 21.89

3.02 ± 0.85

≥ 4 to < 12 months

8

65.99 ± 11.76

1.80 ± 0.27

≥ 12 months to < 6 years

2

87.90 ± 20.87

1.58 ± 0.38

≥ 6 years

2

238.9 ± 282.3

3.33 ± 3.92

Total

30

91.79 ± 88.45

2.61 ± 1.38